FDA Approves First Non-Hormonal Copper IUD in Over 40 Years
Miudella achieves similar efficacy to other available copper IUDs with less than half the dose of copper.
Adiponectin to Predict Cardiometabolic Risk in Postmenopausal Women
Among postmenopausal women, researchers investigated the association of cardiometabolic parameters and circulating levels of visfatin, adropin, and adiponectin.
Poor Glycemic Control for Patients With Type 2 Diabetes Increases Risk of Long COVID Symptoms
The increased risk of symptoms only includes respiratory-related symptoms or brain fog.
FDA Clears Tandem’s Automated Insulin Delivery Algorithm For T2D
The technology will be available to patients in the United States in March 2025.
Q&A: Advanced Practice Pharmacist on Nontraditional Roles in Health Care
Crystal Zhou, PharmD, APh, AHSCP, BCACP, joined Drug Topics to further discuss the Cut Hypertension Program and nontraditional roles within health care.
Symbravo Shows Greater Migraine Improvement Compared With Oral CGRP Inhibitors
Meloxicam and rizatriptan (Symbravo, formerly AXS-07) is a CGRP medication approved for the acute treatment of migraine with or without aura.
Topical Medications as First-Line Treatment Options for Orofacial Pain
Researchers investigated the pharmacological management of chronic orofacial pain and provided guidance on its proper treatment.
FDA Grants Emergency Authorization to Aptitude’s COVID, Flu Test
The next-gen molecular Metrix was given emergency use authorization for its ability to test for SARS-CoV-2 and influenza A and B viruses.
Two New Stelara Biosimilars Now Available in US
Yesintek from Biocon Biologics and Pyzchiva from Sandoz will have a patient assistance program that includes benefits verification and copay support.
FDA Approves Updated Buprenorphine Label For Rapid Initiation Treatment
The updated label also includes alternative injection sites, such as the abdomen, thigh, buttock, or back of the upper arm.
Financial Incentives, Advocacy Drives Outpatient Practice Unification
Researchers explore the unification of outpatient practices and the structural racism in large health systems that has caused patient disparities.
Community Pharmacists as Experts on Complex Patient Encounters
Researchers identified factors contributing to Medicaid Managed Care complexities and collected evidence of pharmacists’ ability to address patients’ health needs.
Investigators Find Repurposing Amlodipine as Novel Treatment for ADHD
The study authors report that long-term daily administration of amlodipine induced behavioral changes in the rats during their open field test.
Mental Health First Aid Training Can Help Pharmacists Provide Better Care
Pharmacists who participated in the mental health first aid training had better understanding of mental health conditions and increased confidence and skills in mental health intervention.
FDA Approves Chenodiol for Treatment of Cerebrotendinous Xanthomatosis
Ctexli is the first FDA-approved treatment for adults with cerebrotendinous xanthomatosis.
FDA Says Ozempic, Wegovy Shortage Resolved
Semaglutide has been in shortage since 2022 due to increased demand.
Q&A: Innovative Technologies Revolutionizing Pain Medicine
Physician with expertise in pain research discussed emerging technologies in the future of pain medicine and how they must be adapted to improve patient outcomes.
Texas Health Department Investigating Measles Outbreak as Case Count Reaches 90
Measles is highly contagious, and the Texas Department of State Health Services said that additional cases are likely to occur in Gaines County, which had 57 cases as of February 21, 2025.
Multimodal Regimen Crucial for Treating Burn Injury-Induced Pain
Experts gathered to explore the pathophysiology and therapeutic management of burn injury-induced pain.
Tirzepatide Shows Substantial Weight Loss for Patients With Type 1 Diabetes
Tirzepatide (Mounjaro, Zepbound), a glucagon-like peptide-1 (GLP-1) medication, demonstrates improved diabetes control and decreases in insulin requirements.
Cardiovascular Practice Program Could Help Pharmacists Lower Patient Blood Pressure
A program that includes peer coaching and monitoring tools can help pharmacists better manage hypertension in patients.
The Unique Challenges, Growth in the Business of Health-System Pharmacy
From market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.
Entrepreneurship Necessary to Community Pharmacy Practice, Education
Researchers conducted a literature review to explore topics in entrepreneurship that impact pharmacy practice and education.
Type 1 Diabetes Linked With Increased Dementia Risk
A recent metanalysis found that patients with type 1 diabetes had a 50% higher chance of developing dementia.
FDA Grants Breakthrough Therapy Designation to SkinTE for Wagner Grade 1 Diabetic Foot Ulcers
By 12 weeks, investigators report that SkinTE facilitated significantly more wound closures compared with the standard of care.
Counseling Patients on CGM, Smartphone Compatibility Usage
Recently, the FDA alerted users of missed notifications for continuous glucose monitoring devices and Bluetooth smartphone compatibility.
Q&A: Pharmacist Prescribed Contraception Can Mitigate Barriers to Care
A conversation with Ginger Lemay, PharmD, Jeffrey Bratberg, PharmD, and Audrey Whalen, PharmD.
Community Pharmacies Motivated to Adopt Opioid Overdose Prevention Practices
Researchers measured current pharmacy practices and the future potential of practices geared toward reducing instances of opioid overdose.
ChatGPT Could Help Community Pharmacists Save Time
Researchers conducted a survey of community pharmacists to understand their use, concerns, and opportunities regarding ChatGPT technology in their practice setting.
FDA Accepts New Drug Application for Vatiquinone to Treat Friedreich Ataxia
The FDA also granted priority review, with a Prescription Drug User Fee Act target action date of August 19, 2025.
